2,2-diphenylglycine,
2,2-Diphenylglycine,
3060-50-2,
2-amino-2,2-diphenylacetic acid,
alpha,alpha-Diphenylglycine,
alpha-Aminodiphenylacetic acid,
GLYCINE, 2,2-DIPHENYL-,
MFCD00008048,
UNII-634Y52030L,
EINECS 221-299-6,
NSC 33392,
BRN 0746633,
alpha-Amino-alpha-phenylbenzeneacetic acid,
.alpha.-Aminodiphenylacetic acid,
.alpha.,.alpha.-Diphenylglycine,
YBONNYNNFBAKLI-UHFFFAOYSA-N,
Benzeneacetic acid, .alpha.-amino-.alpha.-phenyl-,
634Y52030L,
Benzeneacetic acid, alpha-amino-alpha-phenyl-,
J-200037,
alpha,alpha-Diphenylglycine, 98%,
Phenytoin Impurity C,
ACMC-20aoje,
AC1L2BQL,
Amino(diphenyl)acetic acid,
Amino(diphenyl)acetic acid #,
2,2-Diphenylglycine, 98%,
4-14-00-01830 (Beilstein Handbook Reference),
SCHEMBL638306,
AMINODIPHENYLACETIC ACID,
Benzeneacetic acid, alpha-amino-alpha-phenyl- (9CI),
CHEMBL3544524,
CTK3J4581,
DTXSID20184674,
ZINC155190,
AC1Q5054,
NSC33392,
NSC-33392,
SBB057223,
AKOS015894403,
ACM3060502,
CM10001,
MCULE-4076224778,
AK309629,
CC-06540,
LS-72603,
DB-047810,
RT-002092,
CS-0060495,
FT-0634627,
ST50308639,
Amino(diphenyl)acetic Acid (2,2-Diphenylglycine),
C-12981,
I04-8925,
Phenytoin Related Compound A, United States Pharmacopeia (USP) Reference Standard,
2,2-Diphenylglycine(Phenytoin Related Compound A), Pharmaceutical Secondary Standard; Certified Reference Material,
Glycine,2-diphenyl-,
Phenytoin sodium Impurity A,
C14H13NO2,
2,2-Diphenylglycine, 98% 5g,
CID18289,
C14-H13-N-O2,
ACN-029916,
CS-T-53819,